Last reviewed · How we verify
NCT07206888: AUSPICIOUS
Advanced Ultrasound Signal Processing of Suspicious Breast Images
trial testing Imaging in Breast Cancer in 252 participants. Enrolling by invitation.
1 January 2037
Quick facts
| Lead sponsor | Johns Hopkins University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 252 |
| Start date | 25 April 2017 |
| Primary completion | 1 January 2037 |
| Estimated completion | 1 January 2037 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Imaging
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Breast Cyst — all drugs for Breast Cyst →
- Microcalcification — all drugs for Microcalcification →
Sponsor
Johns Hopkins University
Who can join
18 and older, female only, with Breast Cancer or Breast Cyst. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate recent developments in ultrasound signal processing to determine if these new techniques can enhance the visibility of important features of interest in breast ultrasound images. Ultrasound signals obtained from both standard ultrasound imaging and ultrasound imaging combined with light (also known as photoacoustic imaging) will be investigated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Generalized contrast-to-noise ratio applied to short-lag spatial coherence ultrasound differentiates breast cysts from solid masses.
Sharma A, Oluyemi ET, Tripathi M, Ambinder EB, et al · · 2025 · PMID 41415217 · DOI 10.1093/radadv/umaf037
Verify or expand the search:
- PubMed search for NCT07206888
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Imaging
Trials testing the same drug.
- NCT06252610 — PET/MRI of Primary Sclerosing Cholangitis · not yet recruiting
- NCT06377553 — PET/MRI for Evaluation of Endometriosis · enrolling by invitation
- NCT06866782 — European Registry of Next Generation Imaging in Advanced Prostate Cancer · recruiting
- NCT06252493 — Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer. · recruiting
- NCT06265272 — Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis · recruiting
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Johns Hopkins University trials
Trials by the same sponsor.
- NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
- NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
- NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
- NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
- NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07206888 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
- Last refreshed: 14 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07206888.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing